Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To test the efficacy of a web-based stepped collaborative care intervention to reduce symptoms of depression, pain, and fatigue and improve health-related quality of life (HRQL) in advanced cancer patients and to reduce stress and depression, and fewer CVD risk factors in caregivers.
The intervention is designed to maintain quality of life for those in greatest need and least access to resources. This innovative and scalable web-based collaborative care intervention is expected not only to improve patients' quality of life, at the end of life, but also reduce caregiver stress and depression, and potentially health morbidity and mortality of patients and spousal and intimate partner caregivers from socioeconomically disadvantaged backgrounds. Study findings are expected to lead to research examining the dissemination and implementation of the intervention.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Stepped collaborative care intervention | Experimental | The 'Stepped Collaborative Care Intervention' includes at least biweekly contact from a care coordinator by phone and face to face visits occurring approximately every 2 months, and 24 hour 7 day a week access to a website that was specifically designed during the pilot study for advanced cancer patients from socioeconomically disadvantaged backgrounds. |
|
| Enhanced Usual Care | Active Comparator | Patients randomized to the 'Enhanced Usual Care' arm receive their usual care from their medical team. However, if the patient scores in the clinical range on one or more of the three symptoms s/he will receive education about the symptom and be referred to the appropriate health care provider for further treatment in their community. The care coordinator will follow up with the patient after 3 weeks to assess barriers to treatment and assist further with accessing treatment if needed. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Stepped collaborative care intervention | Behavioral | Using website that was specifically designed for advanced cancer patient, collaborative with treatment from health professional |
| Measure | Description | Time Frame |
|---|---|---|
| Sleep Quality | Pittsburgh Sleep Quality Index (PSQI) | Change from baseline at 6 months |
| Pain Level | Brief Pain Inventory (BPI) | Change from baseline at 6 months |
| Functioning | Functional Assessment for Cancer Therapy Hepatobiliary (FACT - Hep) | Change from baseline at 6 months |
| Depression | Center for Epidemiological Studies -Depression (CESD) | Change from baseline at 6 months |
| Stress | Perceived Stress Scale (PSS) | Change from baseline at 6 months |
| Fatigue | Functional Assessment for Cancer Therapy Fatigue (FACT - Fatigue) | Change from baseline at 6 months |
| Caregiver Quality of Life | Caregiver Quality of Life Questionnaire (CQOL) | Change from baseline at 6 months |
Not provided
Not provided
Inclusion Criteria:
Biopsy and/or radiograph proven diagnosis of hepatocellular carcinoma, cholangiocarcinoma, gallbladder carcinoma or breast, ovarian, or colorectal cancer with liver metastases with a life expectancy of at least one year; age >21 years; no evidence of thought disorder, delusions, or active suicidal ideation is observed or reported.
A spouse or cohabitating intimate partner of an advanced cancer patient being evaluated the UPMC's Liver Cancer Center and age >21 years
Exclusion Criteria:
Age < 21 years, Lack of fluency in English, Evidence of thought disorder, delusions, hallucinations, or suicidal ideation.
Age < 21 years, Lack of fluency in English, Evidence of thought disorder, delusions, hallucinations, or suicidal ideation.
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jennifer L Steel, PhD | Contact | 14126922041 | steeljl@upmc.edu |
| Name | Affiliation | Role |
|---|---|---|
| Jennifer L Steel | UPMC Department of Surgery | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Pittsburgh Medical Center Montefiore Liver Cancer Center | Pittsburgh | Pennsylvania | 15213 | United States |
De-Identified Data may be shared with investigators who request data from the Primary Investigator
Data will be available at the end of the study for up to one year.
Appropriate investigator credentials (MD, PhD) and request, and for up to one year after study completion
Not provided
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
| D003863 | Depression |
| D005221 | Fatigue |
| D010146 | Pain |
| ID | Term |
|---|---|
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Randomized controlled trial
Not provided
Not provided
Not provided
|
| Enhanced Usual Care | Behavioral | Usual care from health providers |
|
|
| University of Pittsburgh's Medical Center Montefiore Hospital | Pittsburgh | Pennsylvania | 15213 | United States |
|
| D009461 | Neurologic Manifestations |